Approval Probability 71%
TA Base Rate26%
Adjusted LOA41%
ML RiskLOW_RISK
| NCT ID | Title | Phase | Status | Enrollment | Velocity | Design | Start | Completion | Last Updated | Sites | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|
| NCT00132977 | RethinQ Study - Evaluating Pacing in Heart Failure Patients | PHASE3 | COMPLETED | 250 | — | — | Jul 1, 2005 | Jul 1, 2007 | Feb 4, 2019 | 34 | United States |
| Name | Type | Description |
|---|---|---|
| Cardiac Resynchronization Therapy | DEVICE | - |
Inclusion Criteria: * Have an approved indication for implantation of an ICD. * Have advanced HF with a New York Heart Association (NYHA) Classification of III, despite receiving optimal pharmacological therapy. * Have a stable heart failure medical regimen. * Have a left ventricular ejection fract...